Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection

Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection

Maria Chiara Parati,1 Rebecca Pedersini,2 Gianluca Perego,3 Roberto Reduzzi,4 Tommaso Savio,4 Mary Cabiddu,1 Karen Borgonovo,1 Mara Ghilardi,1 Andrea Luciani,1 Fausto Petrelli1 1Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy; 2Breast Unit-Medical Oncology, ASST S...

Full description

Bibliographic Details
Main Authors: Parati MC, Pedersini R, Perego G, Reduzzi R, Savio T, Cabiddu M, Borgonovo K, Ghilardi M, Luciani A, Petrelli F
Format: Article
Language:English
Published: Dove Medical Press 2022-04-01
Series:Breast Cancer: Targets and Therapy
Subjects:
breast cancer
ribociclib
cdk 4/6 inhibitors
review
Online Access:https://www.dovepress.com/ribociclib-in-the-treatment-of-hormone-receptor-positiveher2-negative--peer-reviewed-fulltext-article-BCTT

Internet

https://www.dovepress.com/ribociclib-in-the-treatment-of-hormone-receptor-positiveher2-negative--peer-reviewed-fulltext-article-BCTT

Similar Items